In the context of GC, it has been documented that the presence of SULF1 is correlated with an unfavorable prognosis and an increased risk of lymph node metastases, while several researchers demonstrated that SULF1 inhibited GC cells proliferation and invasion [25, 26]. The gene discussed is SULF1; the disease is metastatic malignant neoplasm in the lymph nodes.